RxDoctor Payments Data

Brenda Halstead, NP

Acute Care · Richmond, VANPI 1992765259

Payments from drug & device makers

$442in general payments, 2019–2025

Across 21 payments — averaging $21.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$137
  • AstraZeneca$52
  • Otsuka America Pharmaceutical, Inc.$48
  • Ardelyx, Inc.$41
  • OPKO Pharmaceuticals, LLC$39
  • Akebia Therapeutics Inc$39
  • plus $86 from 4 others

What the payments were for

  • Food & beverage$42195%
  • Education$205%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$442 in reported general payments places this provider in the 55th percentile of 599 acute care providers in Virginia.

See all acute care providers in Virginia

Medicare billing

Part B allowed, 2024
$12,180
Medicare patients
35
Services billed
226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AuryxiaFerric Citrate23$48,059
ClinolipidFat Emulsion/Olive/Soy/Phospho110$29,591
ProsolParenteral Amino Acid 20% No.1152$26,907
Sevelamer Carbonate112$20,393
Lanthanum Carbonate12$14,775
LokelmaSodium Zirconium Cyclosilicate11$8,879
Midodrine Hcl42$1,618
Ventolin HfaAlbuterol Sulfate14$786
Nifedipine ErNifedipine30$750
Pantoprazole Sodium48$552
Lidocaine-PrilocaineLidocaine/Prilocaine20$549
Furosemide27$427
Amlodipine Besylate45$193
Atorvastatin Calcium15$160
Hydralazine Hcl19$142

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Akebia Therapeutics IncAuryxia$39$48,05923 claims
AstraZenecaLokelma$52$8,87911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 599 acute care providers in Virginia.

Other acute care in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →